Overexpression of SMYD2 contributes to malignant outcome in gastric cancer.
Komatsu S, Ichikawa D, Hirajima S, Nagata H, Nishimura Y, Kawaguchi T, Miyamae M, Okajima W, Ohashi T, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Imoto I, Inazawa J, Otsuji E.
Komatsu S, et al. Among authors: shiozaki a.
Br J Cancer. 2015 Jan 20;112(2):357-64. doi: 10.1038/bjc.2014.543. Epub 2014 Oct 16.
Br J Cancer. 2015.
PMID: 25321194
Free PMC article.